Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
21 04 2020
Historique:
received: 17 12 2019
accepted: 10 02 2020
pubmed: 20 2 2020
medline: 7 4 2021
entrez: 20 2 2020
Statut: epublish

Résumé

Cefazolin has become a prominent therapy for methicillin-susceptible

Identifiants

pubmed: 32071048
pii: AAC.02511-19
doi: 10.1128/AAC.02511-19
pmc: PMC7179603
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-lactamase CMY-2 EC 3.5.2.-
beta-Lactamases EC 3.5.2.6
Cefazolin IHS69L0Y4T

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI121296
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134637
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI143229
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Antimicrob Chemother. 2013 Dec;68(12):2773-8
pubmed: 23794599
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):349-55
pubmed: 25213722
Open Forum Infect Dis. 2018 May 23;5(6):ofy123
pubmed: 29977970
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
Clin Microbiol Infect. 2018 Feb;24(2):152-158
pubmed: 28694202
J Infect Chemother. 2018 Mar;24(3):212-215
pubmed: 29198902
Antimicrob Agents Chemother. 2009 Aug;53(8):3437-41
pubmed: 19487449
Clin Microbiol Infect. 2018 Feb;24(2):125-132
pubmed: 28698037
Biochem J. 1975 Nov;151(2):197-218
pubmed: 1218078
Antimicrob Agents Chemother. 2011 Nov;55(11):5122-6
pubmed: 21825299
Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):321-31
pubmed: 6109327
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28760895
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Diagn Microbiol Infect Dis. 2015 Nov;83(3):286-91
pubmed: 26277619
Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14
pubmed: 24293654
Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):285-294
pubmed: 27714592
J Infect Dis. 1973 Oct;128:Suppl:S386-9
pubmed: 4744022
Clin Infect Dis. 2020 Mar 3;70(6):1021-1028
pubmed: 31245810
J Bacteriol. 1996 Dec;178(24):7248-53
pubmed: 8955409
Antimicrob Agents Chemother. 1992 Feb;36(2):440-5
pubmed: 1605608
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Clin Microbiol Rev. 2012 Apr;25(2):362-86
pubmed: 22491776
JAMA Pediatr. 2015 Dec;169(12):1105-11
pubmed: 26502073
Pharmacotherapy. 2017 Mar;37(3):346-360
pubmed: 28035690
Clin Infect Dis. 2003 Nov 1;37(9):1194-8
pubmed: 14557964
J Antimicrob Chemother. 2019 Oct 1;74(10):2825-2843
pubmed: 31170287
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Agents Chemother. 1998 Dec;42(12):3163-8
pubmed: 9835509
Nucleic Acids Res. 1986 Jul 25;14(14):5940
pubmed: 3488540
Biochem J. 1965 Mar;94:584-93
pubmed: 14342258
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S183-97
pubmed: 20731576
J Infect Dis. 1989 Jan;159(1):103-8
pubmed: 2783329
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18091-6
pubmed: 22025717
Rev Infect Dis. 1989 May-Jun;11(3):361-8
pubmed: 2664999
FEMS Microbiol Lett. 1990 Jun 1;57(3):249-54
pubmed: 2210337
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Antimicrob Agents Chemother. 2014 Sep;58(9):5117-24
pubmed: 24936596
Clin Infect Dis. 2011 Feb 1;52(3):e18-55
pubmed: 21208910
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891607
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384
Clin Infect Dis. 2017 Jul 1;65(1):100-106
pubmed: 28379314
Antimicrob Agents Chemother. 1990 Mar;34(3):420-5
pubmed: 2334154
Emerg Infect Dis. 2019 Jan;25(1):171-174
pubmed: 30561319

Auteurs

Lina P Carvajal (LP)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Sandra Rincon (S)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Aura M Echeverri (AM)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Jessica Porras (J)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Rafael Rios (R)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Karen M Ordoñez (KM)

E.S.E. Hospital Universitario San Jorge de Pereira, Risaralda, Colombia.

Carlos Seas (C)

Hospital Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.

Sara I Gomez-Villegas (SI)

Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.

Lorena Diaz (L)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Cesar A Arias (CA)

Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Department of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Center for Infectious Diseases, School of Public Health, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.

Jinnethe Reyes (J)

Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia reyesjinnethe@unbosque.edu.co.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH